> top > docs > PMC:7795856 > spans > 30-373 > annotations

PMC:7795856 / 30-373 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
18 98-101 Gene denotes Tα1 Gene:134864
20 156-173 Species denotes hepatitis B virus Tax:10407
24 175-178 Species denotes HBV Tax:10407
31 184-218 Disease denotes hepatitis C virus (HCV) infections MESH:D006526
32 297-305 Disease denotes COVID-19 MESH:C000657245
33 306-316 Disease denotes infections MESH:D007239
34 321-327 Disease denotes cancer MESH:D009369

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 53-61 Phenotype denotes Oncology http://purl.obolibrary.org/obo/HP_0002664
T2 156-165 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T3 184-193 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T4 321-327 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 76-84 Sentence denotes Abstract
T4 85-328 Sentence denotes Thymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer.